Correlation Between Lipella Pharmaceuticals and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Lipella Pharmaceuticals and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipella Pharmaceuticals and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lipella Pharmaceuticals Common and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Lipella Pharmaceuticals and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipella Pharmaceuticals with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipella Pharmaceuticals and Anebulo Pharmaceuticals.
Diversification Opportunities for Lipella Pharmaceuticals and Anebulo Pharmaceuticals
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Lipella and Anebulo is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Lipella Pharmaceuticals Common and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Lipella Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipella Pharmaceuticals Common are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Lipella Pharmaceuticals i.e., Lipella Pharmaceuticals and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Lipella Pharmaceuticals and Anebulo Pharmaceuticals
Given the investment horizon of 90 days Lipella Pharmaceuticals Common is expected to generate 1.76 times more return on investment than Anebulo Pharmaceuticals. However, Lipella Pharmaceuticals is 1.76 times more volatile than Anebulo Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about 0.02 per unit of risk. If you would invest 329.00 in Lipella Pharmaceuticals Common on November 8, 2024 and sell it today you would earn a total of 136.00 from holding Lipella Pharmaceuticals Common or generate 41.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lipella Pharmaceuticals Common vs. Anebulo Pharmaceuticals
Performance |
| Timeline |
| Lipella Pharmaceuticals |
| Anebulo Pharmaceuticals |
Lipella Pharmaceuticals and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lipella Pharmaceuticals and Anebulo Pharmaceuticals
The main advantage of trading using opposite Lipella Pharmaceuticals and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipella Pharmaceuticals position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.| Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
| Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |